Drug Profile
S 44497
Alternative Names: S44497Latest Information Update: 23 Jul 2015
Price :
$50
*
At a glance
- Originator Servier
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 23 Jul 2015 No recent reports on development was identified - Phase-II for Solid tumours in Europe (IV) - Phase-II for Type-2 diabetes mellitus in United Kingdom, Spain, Germany (PO)
- 08 Sep 2011 S 44497 is still in phase II trials for Type-2 diabetes mellitus in Spain